Prof Paramala J Santosh
Professor Paramala J Santosh, MBBS, Dip NB (Psych), MD, Ph.D, FRCPsych
Developmental Neuropsychiatry & Psychopharmacology
Department of Child and Adolescent Psychiatry
King's College London
The King’s College of London (KCL) is one of England’s oldest and most prestigious university institutions and a leading institute for medical research. The Institute of Psychiatry (IoP) is Europe’s largest centre for research and post-graduate education in psychiatry, psychology, basic and clinical neuroscience and one of the world’s leading centres for the study of psychosis and autism. World renowned for the quality of our research, for psychiatry and psychology, we are the most cited research centre outside the US, and the second most cited in the world as ranked by Thomson ISI Essential Science Indicators. In the 2008 Research Assessment Exercise we were judged to have the highest research power of any UK institution within the areas of psychiatry, neuroscience and clinical psychology. Clinical activities linked to the local NHS Trust (South London and Maudsley NHS Trust (SLaM)) account for approximately twenty per cent of the Institute’s income. Our world-class research-led learning experience attracts the very best students from around the world.
KCL project staff is WP leader of WP2
The goal of WP2 is to develop a low burden, reliable and efficient, bespoke MILESTONE Suite of Measures related to transitioning from CAMHS to AMHS. The rating scales will have versions to be completed by adolescents/ parents/ clinicians and adults/ partners/ parents/ clinicians and will be developed such that it can be used as a web-based system using the HealthTracker technology platform, which simplifies administration, scoring and determination of cut-offs for clinical concern. The HealthTrackerTM system is an online multi-media suite of questionnaires that allows accurate measures of change across a wide range of symptoms, side-effects, psychological functions and quality of life. All the monitoring instruments being used in the programme will be uploaded onto the HealthTrackerTM system, which will be used for e-monitoring and data capture.
More specifically, the objectives of WP2 are:
- To develop, and translate the MILESTONE Suite of Instruments (a. Transition related Outcome Measure (TrOM) for successful transitions and b. The Transition Readiness Measure (TRaM) that identifies high-risk, high-need cases for whom transition to AMHS is critical)
- To add the Transition related Outcome Measures (TrOMs) and Transition Readiness Measure (TRaM) and its translations to the HealthTrackerTM
- To assist and train all Centres to use the web-based customized HealthTrackerTM system
- To optimise the TRaM on HealthTrackerTM based on Decision Making Algorithms (to serve as the platform for optimization of transitions to Adult Mental Health in the EU).